Ott, Ina M <br/><br/>
Effects of stimulation of soluble guanylate cyclase on diabetic nephropathy in diabetic eNOS knockout mice on top of angiotensin II receptor blockade.  [electronic resource] 

 -  PloS one  2012 
 - e42623 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0042623  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin II Type 1 Receptor Blockers--administration & dosage<br/>Animals<br/>Benzimidazoles--administration & dosage<br/>Benzoates--administration & dosage<br/>Biomarkers--blood<br/>Blood Glucose--drug effects<br/>Blood Pressure--drug effects<br/>Diabetic Nephropathies--drug therapy<br/>Disease Models, Animal<br/>Guanylate Cyclase--antagonists & inhibitors<br/>Kidney Function Tests<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Nitric Oxide Synthase Type III--genetics<br/>Organ Size--drug effects<br/>Pyrazoles--administration & dosage<br/>Pyrimidines--administration & dosage<br/>Receptors, Angiotensin--metabolism<br/>Receptors, Cytoplasmic and Nuclear--antagonists & inhibitors<br/>Soluble Guanylyl Cyclase<br/>Telmisartan